GlassScriptPhysician profile
Brooke Jackson Kahn
NPI 1295245553
$1,428.86
in general payments reported to CMS, 2019-2025
11 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $165 · 2023: $339 · 2024: $551 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $631.46 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbott Laboratories | $188.10 | 2023-2024 | Eterna, Proclaim |
| Vericel Corporation | $175.79 | 2025 | Nexobrid |
| Medline Industries LP | $138.64 | 2021 | |
| Access Pro Medical, LLC | $133.28 | 2023 | Matriderm |
| Janssen Pharmaceuticals, INC | $44.90 | 2024 | Spravato |
| Medtronic, INC. | $36.32 | 2023-2025 | Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $25.74 | 2021 | |
| Abbvie INC. | $20.27 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.99 | 2022 | |
| Boston Scientific Corporation | $16.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.